Dachaigh › Ailseachadh nan Sgamhan › Maine

Sgrùdaidhean clionaigeach Ailseachadh nan Sgamhan ann an Maine

Tha 12 sgrùdaidhean airson Ailseachadh nan Sgamhan a’ lorg phàirtichean aig làraichean ann an Maine.

Bailtean ann an Maine

Teacsa sgrùdaidh oifigeil (Beurla)

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Lafayette Family Cancer Center-EMMC, Brewer

A’ fastadhÌre 3

Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06096844

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Harold Alfond Center for Cancer Care, Augusta
MaineHealth Waldo Hospital, Belfast
Lafayette Family Cancer Center-EMMC, Brewer
agus 5 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Harold Alfond Center for Cancer Care, Augusta
MaineHealth Waldo Hospital, Belfast
Lafayette Family Cancer Center-EMMC, Brewer
agus 9 a bharrachd

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain

Aoisean 40 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT05334069

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Harold Alfond Center for Cancer Care, Augusta
MaineHealth Maine Medical Center- Scarborough, Scarborough
MaineHealth Cancer Care and IV Therapy - South Portland, South Portland

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

New England Cancer Specialists ( Site 0095), Westbrook

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06312137

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Maine Medical Center, Portland
MaineHealth Cancer Care and Blood Disorders Scarborough, Scarborough
MaineHealth Cancer Care and IV Therapy - South Portland, South Portland

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06758401

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Local Institution - 0127, Scarborough

A’ fastadhÌre 2/3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07063745

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

MaineHealth Maine Medical Center - Portland, Portland
MaineHealth Cancer Care Center of York County, Sanford
MaineHealth Maine Medical Center- Scarborough, Scarborough
agus 1 a bharrachd

A’ fastadhÌre 3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Lafayette Family Cancer Center-EMMC, Brewer

A’ fastadhÌre 2

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Harold Alfond Center for Cancer Care, Augusta
MaineHealth Waldo Hospital, Belfast
Lafayette Family Cancer Center-EMMC, Brewer
agus 5 a bharrachd

A’ fastadhÌre 2/3

Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Lafayette Family Cancer Center-EMMC, Brewer

A’ fastadhÌre 2

18 Minutes · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06031688

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Scarborough

A’ fastadhSgrùdadh amharc

Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.